Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pure Bioscience (PURE)

Pure Bioscience (PURE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 127,127
  • Shares Outstanding, K 87,073
  • Annual Sales, $ 1,910 K
  • Annual Income, $ -6,550 K
  • 60-Month Beta 0.07
  • Price/Sales 35.51
  • Price/Cash Flow N/A
  • Price/Book 40.94
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 06/11/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1035 +36.84%
on 07/15/20
1.6400 -7.93%
on 07/13/20
-0.1300 (-7.93%)
since 07/10/20
3-Month
0.7010 +115.41%
on 05/15/20
2.0500 -26.34%
on 06/11/20
+0.7875 (+109.00%)
since 05/12/20
52-Week
0.2000 +655.00%
on 11/21/19
2.0500 -26.34%
on 06/11/20
+1.1800 (+357.58%)
since 08/12/19

Most Recent Stories

More News
PURE Bioscience Appoints Vice President of Technology, Food Division

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today announced the appointment of Jason Kawata as its new Vice President of Technology,...

PURE : 1.5100 (+3.42%)
PURE Bioscience Reports Fiscal 2020 Third Quarter and Nine-Month Financial Results

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2020...

PURE : 1.5100 (+3.42%)
PURE Bioscience, Inc. Announces Strategic Alliance with Marathon Group, LLC and Whiting Systems, Inc.

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, has entered into a strategic alliance with Marathon Group, LLC and Whiting Systems,...

PURE : 1.5100 (+3.42%)
PURE Bioscience Announces Exclusive Distribution Partnership with PSSI

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antiviral/antibacterial, and Packers Sanitation Services, Inc. (PSSI), have entered into an exclusive...

PURE : 1.5100 (+3.42%)
North America Natural Sweeteners Market Expected to Reach the Production Value USD 851.725 Million by 2025

According to a new report by EMR titled, '', the is significantly aided by the stevia market, which grew at a CAGR of 8.5% between 2015 and 2019. The stevia market is expected to reach the production...

STEV : 0.0015 (-21.05%)
STVF : 0.0550 (+3.77%)
PURE : 1.5100 (+3.42%)
GLG : 3.73 (-1.32%)
GLG.TO : 0.240 (-4.00%)
ADM : 44.59 (+0.45%)
INGR : 83.19 (+0.84%)
Ingredion To Acquire Controlling 75% Stake in PureCircle

Transaction - Benefits Customers, Drives Growth Synergies & Significant Savings for Both Companies

INGR : 83.19 (+0.84%)
PURE : 1.5100 (+3.42%)
PURE Bioscience's PURE(R) Hard Surface Disinfectant Added to EPA's COVID-19 Disinfectant List

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today announced its PURE(R) Hard Surface disinfectant (EPA Reg. No. 72977-5-73912)...

PURE : 1.5100 (+3.42%)
PURE Bioscience Receives Order for Shipment of PURE(R) Hard Surface Disinfectant to Asia

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today announced it received a purchase order to ship EPA-registered PURE(R) Hard Surface...

PURE : 1.5100 (+3.42%)
PURE Bioscience Reports Fiscal 2020 Second Quarter and Six-Month Financial Results

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal second quarter and six-month period...

PURE : 1.5100 (+3.42%)
PURE Bioscience Reports Fiscal 2020 Q1 Financial Results

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2019....

PURE : 1.5100 (+3.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade PURE with:

Key Turning Points

2nd Resistance Point 1.5867
1st Resistance Point 1.5233
Last Price 1.5100
1st Support Level 1.4233
2nd Support Level 1.3867

See More

52-Week High 2.0500
Last Price 1.5100
Fibonacci 61.8% 1.3433
Fibonacci 50% 1.1250
Fibonacci 38.2% 0.9067
52-Week Low 0.2000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar